“…Thirteen papers were characterized as hospital‐level studies, among which nine were performed for preventive interventions. In these nine studies, MCDA was used to evaluate the selection process for new medical devices (Lu, Lin, & Tzeng, ; Ivlev, Vacek, & Kneppo, ; Nobre, Trotta, & Gomes, ; Ahmadi, Nilashi, & Ibrahim, ), to assess quality care in hospitals (Akdag, Kalayci, Karagoz, Zulfikar, & Giz, ; Wang, Chang, Liu, & Chen, ; Longaray et al, ), to compare surgical approaches (Diaz‐Ledezma and Parvizi, ), to develop a process for site selection (Vahidnia et al, ), to set a new fee schedule (Hung et al, ), and to support HTA decision‐making processes (Ritrovato, Faggiano, Tedesco, & Derrico, ). One study (Koch & Rowell, ) was concerned with treatment interventions and aimed at assessing an organ transplant allocation process.…”